Clinical Trial: Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Phase IV Multicentric Study, 140 Patients Suffering of Meibomian Glands Dysfunction.

Brief Summary:

Multicentric study, open label, uncontrolled phase IV in 30 patients with meibomian glands dysfunction .

Its objective is to Collect information from patients and ophthalmologists specialized in ocular surface and eyelids to anticipate how Blephasteam ® can be optimized.

This study involves 2 visits, visit of Inclusion, J0, then end of study visit, D21.

Between the two visits patients will be treated with Blephasteam ® for 21 days (up to two uses per day) and complete a questionnaire every two days during the first week and then once a week the next two weeks.

Detailed Summary:
Sponsor: Laboratoires Thea

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Laboratoires Thea

Dates:
Date Received: August 25, 2010
Date Started: June 2010
Date Completion:
Last Updated: June 7, 2011
Last Verified: June 2011